Isis and Biogen Idec
have been nominated this year for the Thomson Reuters 2013 Breakthrough Alliance Deal of the Year
for their Broad Neurological Disease Alliance.
Please vote for us!

Vote Here

Current Advances

Reduction of a Novel Energy-Regulating Target with Antisense Compound Protects against Diet-induced Weight Gain and Enhances Insulin Sensitivity

Learn More